Bioventus Inc. (BVS) Form 8-K Summary

Date of Filing: November 4, 2025

Bioventus filed this Form 8-K to announce the release of its financial results for the three and nine months ended September 27, 2025.

• Material Event: Item 2.02 reports the issuance of a press release detailing Q3 2025 financial performance (Exhibit 99.1).
• Investor Action Required: Specific financial metrics, performance, or guidance are located only in the furnished Exhibit 99.1, not in this report body.
• Regulatory Status: The company confirms it is an Emerging Growth Company and has